0001179110-20-010869.txt : 20201106
0001179110-20-010869.hdr.sgml : 20201106
20201106163036
ACCESSION NUMBER: 0001179110-20-010869
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201104
FILED AS OF DATE: 20201106
DATE AS OF CHANGE: 20201106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobson Allan Steven
CENTRAL INDEX KEY: 0001579003
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 201294859
MAIL ADDRESS:
STREET 1: PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
edgar.xml
FORM 4 -
X0306
4
2020-11-04
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001579003
Jacobson Allan Steven
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
1
0
0
0
Common Stock
2020-11-04
4
M
0
20000
10.85
A
23498
D
Common Stock
2020-11-04
4
S
0
20000
60.00
D
3498
D
Stock Option (Right To Buy)
10.85
2020-11-04
4
M
0
20000
10.85
D
2023-05-15
Common Stock
20000
23000
D
Stock Option (Right To Buy)
490.8
2021-04-27
Common Stock
250.0
250
D
Stock Option (Right To Buy)
218.4
2022-01-10
Common Stock
83.0
83
D
Stock Option (Right To Buy)
27.05
2024-01-27
Common Stock
10000.0
10000
D
Stock Option (Right To Buy)
51.0
2025-01-01
Common Stock
12000.0
12000
D
Stock Option (Right To Buy)
30.86
2026-01-03
Common Stock
12000.0
12000
D
Stock Option (Right To Buy)
11.23
2027-01-02
Common Stock
12000.0
12000
D
Stock Option (Right To Buy)
18.01
2028-01-02
Common Stock
14000.0
14000
D
Stock Option (Right To Buy)
33.02
2029-01-21
Common Stock
14000.0
14000
D
Stock Option (Right To Buy)
51.16
2030-01-28
Common Stock
10000.0
10000
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2020.
Currently exercisable.
This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020.
/s/ Avraham S. Adler, attorney-in-fact
2020-11-06